Argenta Global

Argenta is a global contract research, development, and manufacturing organization (CRO/CDMO) dedicated exclusively to the animal health and nutrition industry. Operating from a "molecule to market" framework, the company provides comprehensive services including drug delivery, pharmaceutical development, regulatory affairs, and preclinical and clinical research. Their infrastructure includes four EMA- and FDA-approved, GMP-compliant manufacturing facilities located in the United States, New Zealand, and Scotland. These sites possess specialized capabilities, ranging from sterile injectables and solid dosage forms to high-containment hormone facilities and proprietary intraruminal capsule technologies, allowing them to support products from initial formulation through to commercial-scale packaging.

By serving as an end-to-end partner for companies ranging from small enterprises to industry leaders, Argenta helps streamline the product development lifecycle and mitigate financial risks for its clients. The company leverages a multidisciplinary team of over 1,000 specialists—including veterinarians, animal scientists, and engineers—to solve complex development challenges. This collaborative approach has established Argenta as a recognized leader in the field, evidenced by multiple S&P Global Animal Health Awards for best services company and their involvement in the development of novel therapies such as monoclonal antibodies and stem cells. Through these capabilities, Argenta supports the delivery of world-class animal health treatments and therapies globally.